We believe control of the Senate is a toss-up, although, if forced to choose, we give Republicans a slight edge in retaining control of the upper chamber. We continue to think Democrats are very likely…

With the November elections less than two months away, we assess how different congressional outcomes could reshape the healthcare legislative agenda for health insurers, pharmacy benefit managers (PBMs), 340B contract pharmacies, and health savings account…

With CMS set to release its finalized update to the TAVR NCD by Sept. 13 [likely posted after the close here], we largely expect it to maintain the core elements of the original proposal. More…

Our review of stakeholder feedback on CMS’s CY27 Medicare payment rule for dialysis centers [DVA, FRE.DE, private US Renal Care and Innovative Renal Care] leaves us expecting a final rule similar to the June proposal,…

The House is in session this week but will be out next week for the Labor Day district work period. The Senate will not return until the week of September 14. In addition to looking…

Following reports that the Trump administration is considering eliminating the tariff exemptions for data centers and extending Sec. 232 semiconductor tariffs to servers and other chip products, we assign ~70% odds that Trump announces expanded…

Bloomberg is reporting that the White House intends to “announce a new round of drug pricing agreements with several midsized biotech companies on Monday,” and that “in exchange, the companies will be exempt” from the…

We think Meta’s (META) settlement with state attorneys general (AG) is positive for the company and the social media industry. The state AG cases were the largest and most advanced litigation threat facing the company,…

This fall seems likely to be a busy one for medtech and biopharma, with key policy catalysts coming up for a number of companies. These span from both the far-reaching in terms of most favored…

The pending Contract Year (CY) 2028 Technical and Policy Changes proposal for the Medicare Advantage (MA) insurers [HUM, ALHC, UNH, CVS, ELV, CNC, CLOV, MOH] and MA-exposed providers [AGL, ASTH] could be relatively more consequential…

We continue to believe the odds Democrats win control of the House are greater than 80%, while we give Republicans roughly a 60% chance of retaining the Senate. In this note, we are focusing on…

Following HTFL’s strong 2Q26 results, we have received a number of questions on how Medicare hospital outpatient reimbursement might evolve in light of CMS’s proposal to eventually establish a new payment paradigm for software as…

We wanted to update you on California’s AB 1709, which would restrict personalized feeds, autoplay and other addictive features for users under 16 and would negatively affect Meta (META), Alphabet (GOOGL), Snap (SNAP), Pinterest (PINS),…

Through 2028, Obamacare enrollment faces two statutory headwinds after the large, still unfolding 2026 reset: The 2027 narrowing of ACA subsidy eligibility for certain non-citizens. The 2028 installation of pre-enrollment subsidy eligibility verification. For exchange…

With GKOS’s strong 2Q26 results coming on the heels of five separate MAC stakeholder meetings on the draft iDose LCDs issued in late May, we suspect the final policy – likely out in Oct. /…